Rheumatoid factor positivity in antineutrophil cytoplasmic antibody-associated vasculitis: a distinct clinical entity or innocent bystander?

Author:

Ahn Sung Soo1ORCID,Ha Jang Woo2,Park Yong-Beom23,Lee Sang-Won23ORCID

Affiliation:

1. Department of Internal Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin

2. Division of Rheumatology, Department of Internal Medicine

3. Institute for Immunology and Immunological Diseases, Yonsei University College of Medicine, Seoul, Republic of Korea

Abstract

Abstract Objective To investigate the significance of RF positivity in ANCA-associated vasculitis (AAV) patients. Methods AAV patients were divided into groups as follows: RF (+)/ANCA (+) (n = 94), RF (−)/ANCA (+) (n = 80), RF (+)/ANCA (−) (n = 15) and RF (−)/ANCA (−) (n = 25). Their clinical data, organ involvement patterns, laboratory data, and patient outcomes were assessed. Kaplan–Meier analysis and propensity score matching (PSM) were performed to compare outcomes and analyse differences between the groups. Results Of the 214 patients, RF and ANCA positivity was found in 109 (50.9%) and 174 (81.3%) patients, respectively. RF (+)/ANCA (+) patients more frequently presented with general manifestations (58.5%) than the other groups. Additionally, compared with those of RF (−)/ANCA (+) group, RF (+)/ANCA (+) patients were older, had higher white blood cell, neutrophil, platelet counts and acute phase reactants; however, creatinine and albumin levels were lower. The end-stage kidney disease-free survival rate was significantly higher in the RF (+)/ANCA (+) group (P =0.013), while the proportion of renal involvement was comparable to the RF (−)/ANCA (+) group. PSM showed no difference in patient outcomes between the two groups after adjustment. Conclusion RF positivity was associated with a distinct phenotype in AAV patients. In particular, difference was observed in clinical features and outcomes between RF (+)/ANCA (+) and RF (−)/ANCA (+) groups, although the direct prognostic implication of RF was not evident.

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3